세계의 제약 임상시험 용품 및 물류 시장(2024-2034년)

The global Clinical Trial Supply and Logistics for Pharma market is projected to grow at a CAGR of 9.3% by 2034

The Clinical Trial Supply and Logistics for Pharma Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Advancing Diversity in Clinical Trials

Improving diversity in clinical trials is essential to guaranteeing the safety and effectiveness of medical interventions for all populations. In order to address this imperative, sites and sponsors can play a crucial role by taking proactive steps to encourage diversity and inclusivity in clinical research.

In order to obtain deep insights into the priorities of patient communities, sites and sponsors must first give priority to community engagement. These insights can then be incorporated into study designs and logistical arrangements, such as offering remote and digitally enabled study participation.

Initiatives for community outreach should be long-term commitments that find and apply viable solutions, building confidence and reducing obstacles to participation for marginalised groups. By working together with community organisations, healthcare providers, and advocacy groups, researchers can better understand the social and political factors that influence health, cross linguistic and cultural barriers, spread the word about opportunities for clinical research, and allay fears and misconceptions.

It is recommended that clinical trials be designed with input from trial sites and patient communities in order to minimise barriers to participation and create inclusive eligibility criteria. Encouraging diverse participants by providing patient-centred, culturally competent care throughout the trial process creates a warm and encouraging atmosphere. Additionally, research staff should receive diversity training from sites and sponsors in order to address implicit biases, improve communication skills, and develop cultural sensitivity. Research teams can establish an equitable environment that promotes diverse participation in clinical trials by cultivating an inclusive and respectful culture.

What Questions Should You Ask before Buying a Market Research Report?

How is the clinical trial supply and logistics for pharma market evolving?

What is driving and restraining the clinical trial supply and logistics for pharma market?

How will each clinical trial supply and logistics for pharma submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each clinical trial supply and logistics for pharma submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading clinical trial supply and logistics for pharma markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the clinical trial supply and logistics for pharma projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of

clinical trial supply and logistics for pharma projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the clinical trial supply and logistics for pharma market?

Where is the clinical trial supply and logistics for pharma market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the clinical trial supply and logistics for pharma market today, and over the next 10 years:

Our 275-page report provides 115 tables and 128 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the clinical trial supply and logistics for pharma market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

Type

CTS Manufacturing

CTS Logistics & Distribution

CT Supply Chain Management

CTS Packaging & Storage

Phase

Preclinical

Phase I

Phase II

Phase III

Phase IV

Post Launch

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 26 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Switzerland

Rest of Europe

Asia Pacific

Japan

China

India

Australia

South Korea

South-East Asia

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Colombia

Rest of Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles and for some of the leading companies in the Clinical Trial Supply and Logistics for Pharma Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report

Almac Group

Bilcare Limited

Biocair

Catalent, Inc.

COREX Logistics

Eurofins Scientific

FedEx

ICON plc

Intertek Group plc

Kerry Logistics Network Limited

Kuehne+Nagel

Marken (A UPS Company)

Mayne Pharma Group Limited

Movianto

NAF Pharma

Oximio

Parexel International Corporation

PCI Pharma Services (PCI)

Royal Cargo

Thermo Fisher Scientific Inc.

United Parcel Service, Inc.

Yourway

Overall world revenue for Clinical Trial Supply and Logistics for Pharma Market, 2024 to 2034 in terms of value the market will surpass US$14.0 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Clinical Trial Supply and Logistics for Pharma Market, 2024 to 2034 report help you?

In summary, our 270+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Clinical Trial Supply and Logistics for Pharma Market 2024 to 2034, with forecasts for type and phase, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 26 key national markets - See forecasts for the Clinical Trial Supply and Logistics for Pharma Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 22 of the major companies involved in the Clinical Trial Supply and Logistics for Pharma Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Clinical Trial Supply and Logistics for Pharma Market 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

• 1.1 Objectives of the Study
• 1.2 Introduction to Clinical Trial Supply and Logistics for Pharma Market
• 1.3 What This Report Delivers
• 1.4 Why You Should Read This Report
• 1.5 Key Questions Answered by This Analytical Report Include:
• 1.6 Who is This Report For?
• 1.7 Methodology
  • 1.7.1 Market Definitions
  • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.7.3 Data Validation
    • 1.7.3.1 Primary Research
    • 1.7.3.2 Secondary Research
• 1.8 Frequently Asked Questions (FAQs)
• 1.9 Associated Visiongain Reports
• 1.10 About Visiongain

2 Executive Summary

3 Market Overview

• 3.1 Key Findings
• 3.2 Market Dynamics
  • 3.2.1 Market Driving Factors
    • 3.2.1.1 Move Towards Decentralized/Virtual Trials
    • 3.2.1.2 Increasing Possibilities for Conducting Clinical Trials in Asia Pacific Nations
    • 3.2.1.3 Growing Clinical Trials Volume
    • 3.2.1.4 Integrated Solution to Track Clinical Trials
  • 3.2.2 Market Restraining Factors
    • 3.2.2.1 Clinical Trial and Medical Cold Chain Logistics
    • 3.2.2.2 Man-made or Natural Disruption in Transportation
    • 3.2.2.3 High Financial Cost
  • 3.2.3 Market Opportunities
    • 3.2.3.1 AI and Machine Learning are Evolving with More Data
    • 3.2.3.2 Virtual Trials and Technology Are Gaining Acceptance among Patients and Sites
    • 3.2.3.3 Big Companies are driving the Market
• 3.3 COVID-19 Impact Analysis
• 3.4 Porter's Five Forces Analysis
  • 3.4.1 Bargaining Power of Suppliers
  • 3.4.2 Bargaining Power of Buyers
  • 3.4.3 Competitive Rivalry
  • 3.4.4 Threat of Substitutes
  • 3.4.5 Threat of New Entrants
• 3.5 PEST Analysis

4 Clinical Trial Supply and Logistics for Pharma Market Analysis by Type

• 4.1 Key Findings
• 4.2 Type Segment: Market Attractiveness Index
• 4.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
• 4.4 CTS Manufacturing
  • 4.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 4.4.2 Market Share by Region, 2024 & 2034 (%)
• 4.5 CTS Logistics & Distribution
  • 4.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 4.5.2 Market Share by Region, 2024 & 2034 (%)
• 4.6 CT Supply Chain Management
  • 4.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 4.6.2 Market Share by Region, 2024 & 2034 (%)
• 4.7 CTS Packaging & Storage
  • 4.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 4.7.2 Market Share by Region, 2024 & 2034 (%)

5 Clinical Trial Supply and Logistics for Pharma Market Analysis by Phase

• 5.1 Key Findings
• 5.2 Phase Segment: Market Attractiveness Index
• 5.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
• 5.4 Preclinical
  • 5.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 5.4.2 Market Share by Region, 2024 & 2034 (%)
• 5.5 Phase I
  • 5.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 5.5.2 Market Share by Region, 2024 & 2034 (%)
• 5.6 Phase II
  • 5.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 5.6.2 Market Share by Region, 2024 & 2034 (%)
• 5.7 Phase III
  • 5.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 5.7.2 Market Share by Region, 2024 & 2034 (%)
• 5.8 Phase IV
  • 5.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 5.8.2 Market Share by Region, 2024 & 2034 (%)
• 5.9 Post Launch
  • 5.9.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 5.9.2 Market Share by Region, 2024 & 2034 (%)

6 Clinical Trial Supply and Logistics for Pharma Market Analysis by Region

• 6.1 Key Findings
• 6.2 Regional Market Size Estimation and Forecast
• 6.3 Biopharma Clinical Trial Supply and Logistics Market by Region

7 North America Clinical Trial Supply and Logistics for Pharma Market Analysis

• 7.1 Key Findings
• 7.2 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
• 7.3 North America Clinical Trial Supply and Logistics for Pharma Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 7.4 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
• 7.5 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
• 7.6 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
• 7.7 U.S. Clinical Trial Supply and Logistics for Pharma Market Analysis
• 7.8 Canada Clinical Trial Supply and Logistics for Pharma Market Analysis

8 Europe Clinical Trial Supply and Logistics for Pharma Market Analysis

• 8.1 Key Findings
• 8.2 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
• 8.3 Europe Clinical Trial Supply and Logistics for Pharma Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 8.4 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
• 8.5 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
• 8.6 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
• 8.7 Germany Clinical Trial Supply and Logistics for Pharma Market Analysis
• 8.8 UK Clinical Trial Supply and Logistics for Pharma Market Analysis
• 8.9 France Clinical Trial Supply and Logistics for Pharma Market Analysis
• 8.10 Italy Clinical Trial Supply and Logistics for Pharma Market Analysis
• 8.11 Spain Clinical Trial Supply and Logistics for Pharma Market Analysis
• 8.12 Russia Clinical Trial Supply and Logistics for Pharma Market Analysis
• 8.13 Netherlands Clinical Trial Supply and Logistics for Pharma Market Analysis
• 8.14 Switzerland Clinical Trial Supply and Logistics for Pharma Market Analysis
• 8.15 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Analysis

9 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis

• 9.1 Key Findings
• 9.2 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
• 9.3 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 9.4 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
• 9.5 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
• 9.6 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
• 9.7 Japan Clinical Trial Supply and Logistics for Pharma Market Analysis
• 9.8 China Clinical Trial Supply and Logistics for Pharma Market Analysis
• 9.9 India Clinical Trial Supply and Logistics for Pharma Market Analysis
• 9.10 Australia Clinical Trial Supply and Logistics for Pharma Market Analysis
• 9.11 South Korea Clinical Trial Supply and Logistics for Pharma Market Analysis
• 9.12 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Analysis
• 9.13 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis

10 Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis

• 10.1 Key Findings
• 10.2 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
• 10.3 Latin America Clinical Trial Supply and Logistics for Pharma Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 10.4 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
• 10.5 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
• 10.6 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
• 10.7 Brazil Clinical Trial Supply and Logistics for Pharma Market Analysis
• 10.8 Mexico Clinical Trial Supply and Logistics for Pharma Market Analysis
• 10.9 Argentina Clinical Trial Supply and Logistics for Pharma Market Analysis
• 10.10 Colombia Clinical Trial Supply and Logistics for Pharma Market Analysis
• 10.11 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis

11 MEA Clinical Trial Supply and Logistics for Pharma Market Analysis

• 11.1 Key Findings
• 11.2 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
• 11.3 MEA Clinical Trial Supply and Logistics for Pharma Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 11.4 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
• 11.5 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
• 11.6 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
• 11.7 GCC Clinical Trial Supply and Logistics for Pharma Market Analysis
• 11.8 South Africa Clinical Trial Supply and Logistics for Pharma Market Analysis
• 11.9 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Analysis

12 Company Profiles

• 12.1 Catalent, Inc.
  • 12.1.1 Company Snapshot
  • 12.1.2 Company Overview
  • 12.1.3 Financial Analysis
    • 12.1.3.1 Net Revenue, 2019-2023
    • 12.1.3.2 Regional Market Shares, 2023
  • 12.1.4 Service Benchmarking
  • 12.1.5 Strategic Outlook
• 12.2 Thermo Fisher Scientific Inc.
  • 12.2.1 Company Snapshot
  • 12.2.2 Company Overview
  • 12.2.3 Financial Analysis
    • 12.2.3.1 Net Revenue, 2019-2023
    • 12.2.3.2 R&D, 2019-2023
    • 12.2.3.3 Regional Market Shares, 2023
  • 12.2.4 Service Benchmarking
  • 12.2.5 Strategic Outlook
• 12.3 ICON plc
  • 12.3.1 Company Snapshot
  • 12.3.2 Company Overview
  • 12.3.3 Financial Analysis
    • 12.3.3.1 Revenue, 2019-2023
    • 12.3.3.2 Regional Market Shares, 2023
  • 12.3.4 Service Benchmarking
  • 12.3.5 Strategic Outlook
• 12.4 Eurofins Scientific
  • 12.4.1 Company Snapshot
  • 12.4.2 Company Overview
  • 12.4.3 Financial Analysis
    • 12.4.3.1 Net Revenue, 2019-2022
  • 12.4.4 Services Offered
  • 12.4.5 Strategic Outlook
• 12.5 FedEx
  • 12.5.1 Company Snapshot
  • 12.5.2 Company Overview
  • 12.5.3 Financial Analysis
    • 12.5.3.1 Net Revenue, 2019-2023
    • 12.5.3.2 Regional Market Shares, 2023
  • 12.5.4 Service Benchmarking
• 12.6 United Parcel Service, Inc.
  • 12.6.1 Company Snapshot
  • 12.6.2 Company Overview
  • 12.6.3 Financial Analysis
    • 12.6.3.1 Net Revenue, 2019-2023
  • 12.6.4 Service Benchmarking
• 12.7 KERRY LOGISTICS NETWORK LIMITED
  • 12.7.1 Company Snapshot
  • 12.7.2 Company Overview
  • 12.7.3 Financial Analysis
    • 12.7.3.1 Net Revenue, 2019-2023
    • 12.7.3.2 Regional Market Shares, 2023
  • 12.7.4 Service Benchmarking
• 12.8 Kuehne+Nagel
  • 12.8.1 Company Snapshot
  • 12.8.2 Company Overview
  • 12.8.3 Financial Analysis
    • 12.8.3.1 Net Revenue, 2019-2023
    • 12.8.3.2 Regional Market Shares, 2023
  • 12.8.4 Service Benchmarking
  • 12.8.5 Strategic Outlook
• 12.9 Bilcare Limited
  • 12.9.1 Company Snapshot
  • 12.9.2 Company Overview
  • 12.9.3 Financial Analysis
    • 12.9.3.1 Net Revenue, 2018-2022
    • 12.9.3.2 Regional Market Shares, 2022
  • 12.9.4 Service Benchmarking
• 12.10 Mayne Pharma Group Limited
  • 12.10.1 Company Snapshot
  • 12.10.2 Company Overview
  • 12.10.3 Financial Analysis
    • 12.10.3.1 Net Revenue, 2019-2023
    • 12.10.3.2 Regional Market Shares, 2023
  • 12.10.4 Service Benchmarking
  • 12.10.5 Strategic Outlook
• 12.11 Intertek Group plc
  • 12.11.1 Company Snapshot
  • 12.11.2 Company Overview
  • 12.11.3 Financial Analysis
    • 12.11.3.1 Net Revenue, 2019-2023
  • 12.11.4 Service Benchmarking
• 12.12 Almac Group
  • 12.12.1 Company Snapshot
  • 12.12.2 Company Overview
  • 12.12.3 Service Benchmarking
  • 12.12.4 Strategic Outlook
• 12.13 Parexel International Corporation
  • 12.13.1 Company Snapshot
  • 12.13.2 Company Overview
  • 12.13.3 Service Benchmarking
  • 12.13.4 Strategic Outlook
• 12.14 Biocair
  • 12.14.1 Company Snapshot
  • 12.14.2 Company Overview
  • 12.14.3 Service Benchmarking
  • 12.14.4 Strategic Outlook
• 12.15 Marken (A UPS Company)
  • 12.15.1 Company Snapshot
  • 12.15.2 Company Overview
  • 12.15.3 Service Benchmarking
  • 12.15.4 Strategic Outlook
• 12.16 PCI Pharma Services (PCI)
  • 12.16.1 Company Snapshot
  • 12.16.2 Company Overview
  • 12.16.3 Service Benchmarking
  • 12.16.4 Strategic Outlook
• 12.17 Movianto
  • 12.17.1 Company Snapshot
  • 12.17.2 Company Overview
  • 12.17.3 Service Benchmarking
• 12.18 Yourway
  • 12.18.1 Company Snapshot
  • 12.18.2 Company Overview
  • 12.18.3 Service Benchmarking
• 12.19 COREX Logistics
  • 12.19.1 Company Snapshot
  • 12.19.2 Company Overview
  • 12.19.3 Service Benchmarking
• 12.20 Oximio
  • 12.20.1 Company Snapshot
  • 12.20.2 Company Overview
  • 12.20.3 Service Benchmarking
• 12.21 Royal Cargo
  • 12.21.1 Company Snapshot
  • 12.21.2 Company Overview
  • 12.21.3 Service Benchmarking
• 12.22 NAF Pharma
  • 12.22.1 Company Snapshot
  • 12.22.2 Company Overview
  • 12.22.3 Service Benchmarking

13 Conclusion and Recommendations

• 13.1 Concluding Remarks from Visiongain
• 13.2 Recommendations for Market Players